» Articles » PMID: 38423246

CircUBE3A(2,3,4,5) Promotes Adenylate-uridylate-rich Binding Factor 1 Nuclear Translocation to Suppress Prostate Cancer Metastasis

Overview
Journal Cancer Lett
Specialty Oncology
Date 2024 Feb 29
PMID 38423246
Authors
Affiliations
Soon will be listed here.
Abstract

Metastatic progression is the primary cause of mortality in prostate cancer (PCa) patients. Although circular RNAs (circRNAs) have been implicated in cancer progression and metastasis, our current understanding of their role in PCa metastasis remains limited. In this study, we identified that circUBE3A(2,3,4,5), which originated from exons 2, 3, 4 and 5 of the human ubiquitin-protein ligase E3A (UBE3A) gene, was specifically downregulated in PCa tissues and correlated with the Gleason score, bone metastasis, and D'Amico risk classification. Through the in vitro and in vivo experiments, we demonstrated that overexpression of circUBE3A(2,3,4,5) inhibited PCa cell migration, invasion, metastasis, and proliferation. Mechanistically, circUBE3A(2,3,4,5) was found to bind to adenylate-uridylate-rich binding factor 1 (AUF1), promoting the translocation of AUF1 into the nucleus. This led to decreased AUF1 in the cytoplasm, resulting in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) mRNA instability and a subsequent reduction at the protein level. The downregulation of MTHFD2 further inhibited vimentin expression, thereby suppressing PCa cell epithelial-mesenchymal transition. Additionally, two pairs of the short-inverted repeats (TSIRs) in flanking introns were identified to synergistically facilitate the generation of circUBE3A(2,3,4,5) and other circRNAs. In summary, TSIRs-induced circUBE3A(2,3,4,5) acts as a suppressor of PCa metastasis by enhancing AUF1 nuclear translocation, reducing MTHFD2, and subsequently inhibiting vimentin expression. This study characterizes circUBE3A(2,3,4,5) as a functional circRNA and proposes it as a highly promising target for preventing PCa metastasis.

Citing Articles

CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11.

Song X, Wei Z, Zhang C, Han D, Liu J, Song Y Mol Cancer. 2025; 24(1):53.

PMID: 39994725 PMC: 11852832. DOI: 10.1186/s12943-025-02261-6.


Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer.

Ye C, Liu Z, Xie Q, Tang Y, Zeng J, Feng Z Front Oncol. 2025; 15:1443571.

PMID: 39959665 PMC: 11827427. DOI: 10.3389/fonc.2025.1443571.


RNA-binding protein HNRNPD promotes chondrocyte senescence and osteoarthritis progression through upregulating FOXM1.

Jiang H, Zhang Y, Hu G, Ji P, Ming J, Li Y Commun Biol. 2024; 7(1):1695.

PMID: 39719453 PMC: 11668876. DOI: 10.1038/s42003-024-07407-8.


Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.

Sun X, Huang X, Liu L, Shen W, Zheng F, Liu M Transl Androl Urol. 2024; 13(11):2358-2375.

PMID: 39698574 PMC: 11650353. DOI: 10.21037/tau-24-276.